... Growth Factor Receptor is an Effective Chemopreventive Strategy in the Mouse 4-NQO Model of Oral ...
... , comprehensive treatment plans must include improved chemopreventive strategies. Using the 4-nitroquinoline 1 ...
... -oxide (4-NQO) mouse model, we tested the hypothesis that ZD6474 (Vandetanib, ZACTIMA) is an effective ...
... chemopreventive agent. CBA mice were fed 4-NQO (100 g/mL) in their drinking water for 8 weeks and then randomized ...
... percentage of mice with dysplasia or OSCC was significantly different (96% in the control and 28% in the ...